NHS Tayside Sign Up to Early Warning System Miya Observations

Alcidion LtdNHS Tayside has signed a five-year agreement with smart health tech provider Alcidion to deploy Miya Observations, an electronic monitoring system that will help thousands of busy healthcare professionals as they care for patients.

Formerly known as Patientrack, the system has already delivered substantial clinical benefits in other NHS hospitals, including early adopters in Scotland, where alerts provided by the system and improved visibility of the sickest patients, have helped staff to significantly enhance patient safety and cut cardiac arrests.

NHS Tayside, which employs 14,000 people and serves a population of more than 400,000 across rural and urban communities in Dundee City, Angus and Perth and Kinross, will deploy Miya Observations throughout its regional network.

Miya Observations provides an early warning system that shares critical information as soon as it is recorded, rather than simply passively capturing a patient’s vital signs on a paper-based bedside chart. The system alerts clinical staff when patients show signs of deterioration, so healthcare professionals can rapidly intervene and focus on those patients immediately in need. It has helped hospitals to prevent negative clinical outcomes and to manage risks around deadly conditions including acute kidney injury and sepsis. Hospitals using the system have observed reduced length of stay and many other benefits.

NHS Tayside will use Miya Observations across approximately 975 beds to electronically record vital signs and patient observations, produce charts, automatically calculate patient early warning scores, generate clinical alerts, and document a range of clinical assessments.

Alcidion UK Commercial Director Tom Scott said: "We are thrilled to be partnering with NHS Tayside, extending Miya Observations to a third health board in Scotland. This agreement represents recognition of the benefits that are realised through capturing key clinical data at the bedside, and reporting and acting on it in real time."

Alcidion Group Managing Director Kate Quirke said: "Healthcare technology should exist to deliver benefits to the people delivering and receiving care. It should help to make the right thing to do the easiest thing to do. I look forward to seeing these benefits extend to healthcare professionals and patients in NHS Tayside as the health board deploys Alcidion’s Miya capabilities. It is rewarding to see this success story continue to grow in Scotland, and to be welcoming another important NHS customer in the UK."

About NHS Tayside

Tayside Health Board was established in April 1974 and is responsible for commissioning health care services for the residents in the geographical local government areas of Angus, Dundee and Perth and Kinross.

The Board's boundaries are coterminous with these local government areas, which had a combined population of 416,090 based on mid-year 2017 population estimates published by National Records of Scotland.

NHS Tayside's governance includes three major and a number of community hospitals, including the University of Dundee's Medical School attached to the regions flagship institute, Ninewells Hospital in Dundee. It also includes over 60 GP surgeries and a variety of health centres staffed by thousands of employees of the health region.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...